B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses
Helga Bergholtz(Oslo University Hospital), Thérese Sørlie(Norwegian Cancer Society)
Cited by 0
Related Papers
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition
|Cancer Discovery|2017|242
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy – results from two independent randomized trials
|Acta Oncologica|2017|31